Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors-Reference-Cited by-同舟云学术

Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors

Published:2021-12 Issue:12 Volume:2 Page:1327-1341.e4
ISSN:2666-6340
Container-title:Med
language:en
Short-container-title:Med

Author:

Chen Rita E.,Gorman Matthew J.,Zhu Daniel Y.^ORCID,Carreño Juan Manuel,Yuan Dansu,VanBlargan Laura A.,Burdess Samantha,Lauffenburger Douglas A.^ORCID,Kim Wooseob^ORCID,Turner Jackson S.,Droit Lindsay,Handley Scott A.^ORCID,Chahin Salim^ORCID,Deepak Parakkal^ORCID,O’Halloran Jane A.,Paley Michael A.^ORCID,Presti Rachel M.,Wu Gregory F.^ORCID,Krammer Florian,Alter Galit,Ellebedy Ali H.,Kim Alfred H.J.^ORCID,Diamond Michael S.^ORCID

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Materials Science (miscellaneous)

Reference82 articles.

1. Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19;Sempowski;Cell,2020

2. On the road to ending the COVID-19 pandemic: Are we there yet?;Case;Virology,2021

3. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses;Letko;Nat. Microbiol.,2020

4. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients’ B cells;Cao;Cell,2020

5. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody;Pinto;Nature,2020

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of treatment with original or biosimilar adalimumab on SARS-CoV2 vaccination antibody titers;International Journal of Pharmaceutics: X;2024-06

2. Additional Reassuring Data for SARS-CoV-2 Vaccination in Immune-Mediated Inflammatory Diseases, but With a Catch;The Journal of Rheumatology;2024-02-01

3. COVID-19 in patients with inflammatory bowel diseases: Characteristics and guidelines;Management, Body Systems, and Case Studies in COVID-19;2024

4. Limited antibody response after BA.4‐5 adapted booster vaccination in rheumatic patients receiving anti‐TNF therapy: Results of a case series;Journal of Medical Virology;2023-12

5. Efficacy of COVID-19 vaccines in inflammatory bowel disease patients receiving anti-TNF therapy: A systematic review and meta-analysis;Heliyon;2023-09